21 Jul FDA inspections face overhaul
The agency proposes significant revisions to oversight programs for drugs and medical products....
News
18 Jul It’s high time for gender-inclusive clinical research
Clinical research must be inclusive of all body types and identities....
14 Jul Do decentralized clinical trials help diversify research? Expert @MUSC indicates more evidence necessary
A researcher weighs in on the current state of decentralized clinical trials, their potential to increase participant diversity, and what research is still needed to confirm their efficacy....
11 Jul The best medicine for improving global health? Reduce inequality
The COVID pandemic knocked back progress towards improving public health. Without addressing the underlying social and economic causes of ill health, it could completely stall....
10 Jul Are restrictive LGBTQ+ bills in the US impacting inclusion in clinical trials?
More restrictive LGBTQ+ bills are being passed in the US that might negatively impact transgender individuals in clinical trials....
07 Jul UW Health recruiting volunteers for clinical trial of new Alzheimer’s drug
UW Health is recruiting volunteers for a clinical trial to test a new Alzheimer's drug recently approved by the FDA....
06 Jul Psychedelic research: Experts react to FDA draft guidance
Feedback on the FDA's draft guidance on psychedelic research is mostly positive, but concerns arise around two-monitor recommendation....
06 Jul Alzheimer’s drug Leqembi gets full FDA approval. Medicare coverage will likely follow
The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease....
06 Jul Why the next big hope for Alzheimer’s might not help most Black patients
The FDA is expected to approve the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, some critics predict the rollout of the drug will aggravate racial disparities in elder care....
03 Jul FDA’s DCT draft guidance: A hit or miss?
The much-anticipated draft guidance on DCTs is here, however, it might have missed several important points on delegation and data management....